Comparison between antineoplastic treatments with selective inhibitors (BRAF/MEK) and the new potentials combinatorial therapies for metastatic melanoma. (2022). Research, Society and Development, 11(14), e326111436275. https://doi.org/10.33448/rsd-v11i14.36275